{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:48:13Z","timestamp":1761896893875,"version":"3.37.3"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000765","name":"University College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000765","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UCL"},{"name":"UCLH\/UCL NIHR Biomedical Research Centre"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Magnetic Resonance Imaging"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.mri.2018.10.013","type":"journal-article","created":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T09:49:46Z","timestamp":1540028986000},"page":"34-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Sequential prostate MRI reporting in men on active surveillance: initial experience of a dedicated PRECISE software program"],"prefix":"10.1016","volume":"57","author":[{"given":"Francesco","family":"Giganti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clare","family":"Allen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan W.","family":"Piper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Mirando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armando","family":"Stabile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shonit","family":"Punwani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Kirkham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4230-0338","authenticated-orcid":false,"given":"Mark","family":"Emberton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline M.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mri.2018.10.013_bb0005","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrurol.2016.45","article-title":"Active surveillance for prostate cancer: current evidence and contemporary state of practice","volume":"13","author":"Tosoian","year":"2016","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.mri.2018.10.013_bb0010","series-title":"Implementing the NICE guideline on prostate cancer (CG175)","article-title":"Prostate cancer: protocol for active surveillance","author":"NICE","year":"2014"},{"key":"10.1016\/j.mri.2018.10.013_bb0015","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.eururo.2014.10.050","article-title":"Magnetic resonance imaging in active surveillance of prostate cancer: a systematic review","volume":"67","author":"Schoots","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.mri.2018.10.013_bb0020","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.juro.2016.02.2963","article-title":"How active is active surveillance? Intensity of followup during active surveillance for prostate cancer in the United States","volume":"196","author":"Loeb","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.mri.2018.10.013_bb0025","doi-asserted-by":"crossref","first-page":"620","DOI":"10.2214\/AJR.17.17790","article-title":"Monitoring tumor volume in patients with prostate cancer undergoing active surveillance: is MRI apparent diffusion coefficient indicative of tumor growth?","volume":"209","author":"Morgan","year":"2017","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.mri.2018.10.013_bb0030","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.urology.2014.06.085","article-title":"Magnetic resonance-invisible versus magnetic resonance-visible prostate cancer in active surveillance: a preliminary report on disease outcomes","volume":"85","author":"Dianat","year":"2015","journal-title":"Urology"},{"key":"10.1016\/j.mri.2018.10.013_bb0035","doi-asserted-by":"crossref","DOI":"10.1038\/s41391-018-0058-5","article-title":"The natural history of prostate cancer on MRI: lessons from an active surveillance cohort","author":"Giganti","year":"2018","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.mri.2018.10.013_bb0040","first-page":"0","article-title":"4-year outcomes from an MP-MRI based active surveillance programme - PSA dynamics and serial MRI scans allow omission of protocol biopsies","author":"Gallagher","year":"2018","journal-title":"BJU Int"},{"key":"10.1016\/j.mri.2018.10.013_bb0045","doi-asserted-by":"crossref","DOI":"10.1111\/bju.14358","article-title":"Is magnetic resonance imaging-targeted biopsy a useful addition to systematic confirmatory biopsy in men on active surveillance for low-risk prostate cancer? A systematic review and meta-analysis","author":"Schoots","year":"2018","journal-title":"BJU Int"},{"key":"10.1016\/j.mri.2018.10.013_bb0050","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.eururo.2015.08.052","article-title":"PI-RADS prostate imaging - reporting and data system: 2015, version 2","volume":"69","author":"Weinreb","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.mri.2018.10.013_bb0055","article-title":"Prostate imaging-reporting and data system steering committee: PI-RADS v2 status update and future directions","author":"Padhani","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.mri.2018.10.013_bb0060","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1007\/s00330-015-4015-6","article-title":"Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: critical evaluation using whole-mount pathology as standard of reference","volume":"26","author":"Vargas","year":"2016","journal-title":"Eur Radiol"},{"key":"10.1016\/j.mri.2018.10.013_bb0065","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.eururo.2016.06.011","article-title":"Reporting magnetic resonance imaging in men on active surveillance for prostate cancer: the PRECISE recommendations\u2014a report of a European School of Oncology Task Force","volume":"71","author":"Moore","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.mri.2018.10.013_bb0070","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cct.2012.10.003","article-title":"MAPPED study design: a 6\u202fmonth randomised controlled study to evaluate the effect of dutasteride on prostate cancer volume using magnetic resonance imaging","volume":"34","author":"Robertson","year":"2013","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.mri.2018.10.013_bb0075","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.juro.2016.11.090","article-title":"The effect of dutasteride on magnetic resonance imaging defined prostate cancer: MAPPED\u2014a randomized, placebo controlled, double-blind clinical trial","volume":"197","author":"Moore","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.mri.2018.10.013_bb0080","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1007\/s00330-011-2377-y","article-title":"ESUR prostate MR guidelines 2012","volume":"22","author":"Barentsz","year":"2012","journal-title":"Eur Radiol"},{"key":"10.1016\/j.mri.2018.10.013_bb0085","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1007\/s00330-017-4858-0","article-title":"MRI findings in men on active surveillance for prostate cancer: does dutasteride make MRI visible lesions less conspicuous? Results from a placebo-controlled, randomised clinical trial","volume":"27","author":"Giganti","year":"2017","journal-title":"Eur Radiol"}],"container-title":["Magnetic Resonance Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0730725X18303357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0730725X18303357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T19:32:38Z","timestamp":1717270358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0730725X18303357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":17,"alternative-id":["S0730725X18303357"],"URL":"https:\/\/doi.org\/10.1016\/j.mri.2018.10.013","relation":{},"ISSN":["0730-725X"],"issn-type":[{"type":"print","value":"0730-725X"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sequential prostate MRI reporting in men on active surveillance: initial experience of a dedicated PRECISE software program","name":"articletitle","label":"Article Title"},{"value":"Magnetic Resonance Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mri.2018.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}